During the past decade, Juno Research, LLC conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 17 clinical trials were completed, i.e. on average, 56.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 9 clinical trials were completed. i.e. 52.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Juno Research, LLC" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Pfizer" with 5 trials sponsored, "Ionis Pharmaceuticals, Inc." with 4 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Juno Research, LLC" #1 collaborator was "Integrium" with 2 trials as a collaborator, "Barc NV" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Haupt Pharma Wülfing GmbH" with 1 trials as a collaborator and "Kinexum LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Juno Research, LLC" are "Type 2 Diabetes Mellitus" (9 trials), "Type 2 Diabetes" (8 trials), "Diabetes Mellitus, Type 2" (5 trials), "Diabetes" (4 trials) and "Obesity" (4 trials). Many other conditions were trialed in "Juno Research, LLC" in a lesser frequency.

Most popular intervention types in "Juno Research, LLC" are "Drug" (35 trials), "Other" (7 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Insulin Degludec" (4 trials), "Metformin" (4 trials), "Tirzepatide" (4 trials) and "Diet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Juno Research, LLC" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Juno Research, LLC". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Juno Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Juno Research, LLC, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".